FOXM1 and meningioma: The involvement of the WNT signalling pathway has been recently recognized in meningiomas [39], with the WNT-coupled transcription factor FOXM1 being a key marker for aggressive meningiomas [40]; to note, the WNT pathway communicates with the G protein coupled receptor/PKA pathway to modulate beta-catenin phosphorylation and beta-catenin-dependent transcription [41].